LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 62.66 | 771.67 | 8195 | 8978 | 0.9127 | 0.9491 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 62.66 | 771.67 | 10173 | 8978 | 1.1330 | 1.0718 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 64.88 | 771.67 | 8557 | 9447 | 0.9058 | 0.9460 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 64.88 | 771.67 | 10654 | 9447 | 1.1278 | 1.0677 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 67.10 | 771.67 | 8696 | 9800 | 0.8873 | 0.9359 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 67.10 | 771.67 | 11005 | 9800 | 1.1229 | 1.0642 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 69.32 | 771.67 | 8860 | 10212 | 0.8676 | 0.9252 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 69.32 | 771.67 | 11419 | 10212 | 1.1182 | 1.0609 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 71.54 | 771.67 | 9014 | 10532 | 0.8558 | 0.9191 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 71.54 | 771.67 | 11738 | 10532 | 1.1144 | 1.0583 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 73.76 | 771.67 | 9062 | 10851 | 0.8351 | 0.9077 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 73.76 | 771.67 | 12111 | 10851 | 1.1160 | 1.0584 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 76.02 | 771.67 | 9209 | 11106 | 0.8291 | 0.9049 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 76.02 | 771.67 | 12428 | 11106 | 1.1190 | 1.0593 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 78.25 | 771.67 | 9193 | 11367 | 0.8087 | 0.8935 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 78.25 | 771.67 | 12749 | 11367 | 1.1215 | 1.0600 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 80.48 | 771.67 | 9252 | 11685 | 0.7918 | 0.8844 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 80.48 | 771.67 | 13109 | 11685 | 1.1219 | 1.0595 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 82.69 | 771.67 | 9370 | 11974 | 0.7825 | 0.8798 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 82.69 | 771.67 | 13455 | 11974 | 1.1237 | 1.0598 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 84.92 | 771.67 | 9284 | 12266 | 0.7568 | 0.8651 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 84.92 | 771.67 | 13799 | 12266 | 1.1249 | 1.0599 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 87.14 | 771.67 | 9216 | 12592 | 0.7319 | 0.8509 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 87.14 | 771.67 | 14067 | 12592 | 1.1171 | 1.0557 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 2.49 | 771.67 | 879 | 867 | 1.0130 | 1.1581 | MN20160304_L01 | L18 |